ArticleJournal of virology2015

Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.

Julie Delaloye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.